ECHINACEA Extract 10:1 BN

Echinacea Extract 10:1 BN is a concentrated botanical ingredient derived primarily from the aerial parts and roots of *Echinacea purpurea*, a revered perennial herb indigenous to North America. Historically, Native American tribes utilized Echinacea for centuries due to its perceived therapeutic properties, particularly for immune system support and general wellness. The "10:1" designation signifies that ten parts of the raw Echinacea plant material are concentrated down to yield one part of this potent extract, ensuring a higher concentration of the plant's beneficial compounds compared to a standard powdered herb. This meticulous extraction process aims to preserve the integrity and bioavailability of its key phytochemicals, making it an ideal ingredient for advanced supplement formulations. The resulting fine powder is typically standardized to contain specific markers, guaranteeing consistency and efficacy across batches, which is crucial for product developers seeking reliable botanical inputs.

The primary health benefits of Echinacea are largely attributed to its complex array of bioactive compounds, which collectively exert immunomodulatory and anti-inflammatory effects. Key active constituents include alkylamides, caffeic acid derivatives (such as echinacoside and cichoric acid), polysaccharides, and flavonoids. Research indicates that alkylamides interact with cannabinoid receptors (CB2), potentially influencing immune cell activity and cytokine production, as shown in various *in vitro* and *in vivo* studies. Caffeic acid derivatives, potent antioxidants, contribute to cellular protection and modulate inflammatory pathways. Polysaccharides are believed to stimulate phagocytosis and enhance the activity of natural killer cells, bolstering the body's innate immune response. This synergistic action of multiple compounds positions Echinacea as a multifaceted agent for reinforcing immune resilience.

Echinacea Extract 10:1 BN is highly versatile for incorporation into a wide range of supplement formulations, including capsules, tablets, powders, and liquid tinctures designed for immune support and respiratory health. Its efficacy has been extensively studied, with numerous clinical trials investigating its role in reducing the incidence and duration of the common cold and other upper respiratory tract infections. A meta-analysis published in *The Lancet Infectious Diseases* highlighted Echinacea's potential to decrease the risk of recurrent respiratory infections. When formulating, attention to the extract's standardization for active markers like cichoric acid or alkylamides is paramount to ensure consistent therapeutic benefits. Quality considerations also extend to sourcing, ensuring the raw material is free from pesticides and heavy metals, and that the extraction method maintains the delicate balance of its phytonutrient profile, providing a premium ingredient for high-quality finished products.